| Company/Division name | CSL |
| Parent company | CSL Limited |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2030 |
| Capital investment ($): | 1500 |
| Country(ies) from which reshored: | Australia |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | plasma therapies |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption, Tariffs |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market |
